Mangalam Drugs and Organics Ltd

NSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Mangalam Drugs and Organics Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52W Low on Mar 28, 2024
8.4
TTM PE Ratio
Negative PE TTM
-18.6
Price to Book Ratio
Low in industry
1.2
Dividend yield 1yr %
0
TTM PEG Ratio
0
RSI
RSI is mid-range
51.9
MFI
MFI is mid-range
61.6

Mangalam Drugs and Organics Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Mangalam Drugs and Organics Ltd shareholding Pattern

Promoter
50.3%
Foreign Institutions
0.3%
Public
49.4%
Promoter
50.3%
Foreign Institutions
0.1%
Public
49.6%
Promoter
50.3%
Foreign Institutions
0.1%
Public
49.6%
Promoter
50.3%
Foreign Institutions
0.1%
Public
49.6%
Promoter
50.3%
Foreign Institutions
0.1%
Public
49.6%
Promoter
50.3%
Foreign Institutions
0.1%
Public
49.6%

Mangalam Drugs and Organics Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
11
Bearish Moving Averages
5
5Day EMA
107.80
10Day EMA
107.30
12Day EMA
107.00
20Day EMA
105.80
26Day EMA
105.20
50Day EMA
104.30
100Day EMA
104.20
200Day EMA
105.50
5Day SMA
109.30
10Day SMA
107.90
20Day SMA
105.10
30Day SMA
104.00
50Day SMA
102.60
100Day SMA
106.00
150Day SMA
104.00
200Day SMA
103.60
Delivery & Volume
Resistance & Support
106.74
Pivot
Resistance
First Resistance
108.46
Second Resistance
110.72
Third Resistance
112.44
Support
First Support
104.48
Second support
102.76
Third Support
100.50
Relative Strength Index
51.86
Money Flow Index
61.55
MACD
1.72
MACD Signal
1.48
Average True Range
5.32
Average Directional Index
28.05
Rate of Change (21)
-10.03
Rate of Change (125)
6.21
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Bafna Pharmaceuticals Ltd.
-
-
-
Aarey Drugs & Pharmaceuticals Ltd.
116.24
29.95
68
Krebs Biochemicals & Industries Ltd.
153.77
60.35
93.95
Pharmaids Pharmaceuticals Ltd.
-
-
-
Vaishali Pharma Ltd.
161.26
114.85
203.6
Sotac Pharmaceuticals Ltd
-
-
-

Mangalam Drugs and Organics Ltd Company background

Founded in: 1972
Managing director: Govardhan M Dhoot
Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001. The company was promoted by Dhoot family. The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals.The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra. They also have an inhouse Research and Development (RD) Base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, and dyes and intermediaries.In April 1, 1996 three other group companies, namely Mangalam Organics Pvt Ltd, Shree Mangalam Pharma Pvt Ltd and Mangalam Rasayan Pvt Ltd were amalgamated with the company. In the year 1999, the company launched a new product namely, Nimesulide. In the year 2001, they launched two new products namely Amodiaquine Hydrochloride and Amodiaquine. In the year 20032004, the bulk drug production capacity of the Company was increased from 350 MTPA to 600 MTPA. During the 200405, the capacity is being further enhanced to 960 MTPA. During the year 200506, the company further enhanced their Bulk drug production capacity from 960 MT per annum to 1260 MT per annum.During the year 200708, the company developed and introduced new bulk drugs namely Bisoprolol Fumarate and Pantaprazole Sodium. Also, they increased the production capacity of Meta Chloro Aniline Allied Products from 250 tons to 350 tons.During the year 200910, the company in addition to Regulatory Affairs Cell established Intellectual Property Rights (IPR) cell. The regulatory affairs cell submitted 6 DMFs to WHOGeneva out of which 2 DMFs corresponding to Artemether and Lumefantrine had been approved.During the year 201718, Unit 2 of the Company received WHO Approvals for manufacturing of the Active Pharmaceutical ingredients comprising of Lumefantrine (APIMF100) Tenofovir Disoproxil Fumarate (APIMF204) Artemether (APIMF138) Emtricitabine (WHO API314) Efavirenz (WHO API 318).
Read More

Mangalam Drugs and Organics Ltd FAQs

Mangalam Drugs and Organics Ltd shares are currently priced at 106.21 on NSE and 106.3 on BSE as of 6/20/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Mangalam Drugs and Organics Ltd [MANGALAM] share was -5.25. The Mangalam Drugs and Organics Ltd [MANGALAM] share hit a 1-year low of Rs. 90.8 and a 1-year high of Rs. 132.45.

The market cap of Mangalam Drugs and Organics Ltd is Rs. 168.11 Cr. as of 6/20/2024 12:00:00 AM.

The PE ratios of Mangalam Drugs and Organics Ltd is 0 as of 6/20/2024 12:00:00 AM.

The PB ratios of Mangalam Drugs and Organics Ltd is 1.18 as of 6/20/2024 12:00:00 AM

You can easily buy Mangalam Drugs and Organics Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage